Doctor Rosie Oatham

Northern General Hospital, Sheffield (United Kingdom of Great Britain & Northern Ireland)

Membership: HFA Member

Follow

Contributor content

SGLT2 inhibitors in fabry disease: a real-world evaluation of cardiac and renal biomarker response

Presentation

SGLT2 inhibitors in fabry disease: a real-world evaluation of cardiac and renal biomarker response

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources